Table 1 Characterization of the tolerogenic phenotype of mRNA-electroporated tolDC

42.1 (27.3–56.2)

73.5 (71.9–76.8)^AA,BB

68.7 (66.0–80.1)^A,B

68.0 (65.2–73.8)^A

22.5 (18.4–28.5)

57.5 (23.4–70.3)^A

36.4 (20.5–65.7)

42.5 (19.6–69.5)

17.3 (11.8–27.6)

76.3 (30.7–82.2)^B

70.4 (39.7–82.5)^B

75.5 (39.7–82.5)^A,B

55.1 (37.3–59.4)^A

21.4 (16.8–26.5)

37.0 (29.2–52.0)

60.8 (46.6–71.2)^AAA,CC

3.8 (1.7–4.8)

1.9 (0.8–2.6)^D

2.3 (1.6–4.5)

3.3 (2.3–7.1)

19.85 (10.6–27.0)

4.8 (2.1–5.6)^A,B

4.7 (2.3–5.3)^A,B

3.6 (2.5–5.6)^A,B

1.2 (0.9–1.5)

0.3 (0.1–0.5)^DD,BB

0.3 (0.1–0.4)^B

0.3 (0.1–0.4)^B

12.8 (11.0–21.3)^AAA

7.5 (5.7–10.1)^A

6.0 (4.7–9.4)

7.3 (5.2–9.1)^A

6.0 (4.4–7.8)

2.8 (2.3–5.0)^D,B

2.9 (2.2–3.6)^BB

3.2 (2.8–3.9)^B

356.3 (193.2–409.6)^AAA

73.7 (61.9–132.9)^BBB

74.3 (43.2–98.4)^BBB

99.0 (48.1–122.3)^BBB